Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.
about
Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malariaArtemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malariaArtemisinin-based combination therapy for the treatment of uncomplicated Plasmodium vivax malaria and the prevention of relapsesArtemisinin combination therapy for vivax malariaLung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammationComa associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, IndonesiaA triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor (DSM421) with improved drug-like properties for treatment and prevention of malariaEpidemiology of Plasmodium vivax in IndonesiaFunctional analysis of Plasmodium vivax dihydrofolate reductase-thymidylate synthase genes through stable transformation of Plasmodium falciparumIn vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central EthiopiaContrasting Transmission Dynamics of Co-endemic Plasmodium vivax and P. falciparum: Implications for Malaria Control and EliminationCharacterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy ModelingMalaria Distribution, Prevalence, Drug Resistance and Control in IndonesiaVivax malaria: neglected and not benignGlobal Epidemiology of Plasmodium vivaxNext-Generation Sequencing of Plasmodium vivax Patient Samples Shows Evidence of Direct Evolution in Drug-Resistance Genes.Severe congenital malaria acquired in utero.Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria.Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.Determinants of in vitro drug susceptibility testing of Plasmodium vivax.Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparumAmplification of pvmdr1 associated with multidrug-resistant Plasmodium vivaxVivax malaria: a major cause of morbidity in early infancy.In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria.Resistance to therapies for infection by Plasmodium vivaxRelationship of cell-free hemoglobin to impaired endothelial nitric oxide bioavailability and perfusion in severe falciparum malariaEvaluation of chloroquine therapy for vivax and falciparum malaria in southern Sumatra, western Indonesia.Increased asymmetric dimethylarginine in severe falciparum malaria: association with impaired nitric oxide bioavailability and fatal outcomeAge-related susceptibility to severe malaria associated with galectin-2 in highland PapuansGenetic micro-epidemiology of malaria in Papua Indonesia: Extensive P. vivax diversity and a distinct subpopulation of asymptomatic P. falciparum infectionsIn vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.In vivo and in vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, Indonesia.A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance.Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivaxDihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
P2860
Q24202910-B6FFB007-FE97-45FC-8D17-F7932DD8D4B9Q24235351-A7EB6507-3BC8-496E-9395-2DAC0AA530A8Q24236067-57EE7517-76DA-4D4B-9728-FCAF0506407AQ24622539-3260EAF8-C314-4F86-AB31-26D62DB5444BQ24653650-4CBAA752-BDDD-48EF-B37D-7935088F73CDQ27306352-EE39DA4A-44F1-40E4-B9C9-D353D32074C7Q27728080-DBDB410C-4C3B-48D7-8C73-C44AC9D71F04Q28355357-F43B20C0-7F97-4684-B339-93D04BB74543Q28481173-C678A1B6-1736-4056-BBD1-2E28390CAF7EQ28533253-091F515C-3F29-42A1-87D7-1A3ABCD4AE00Q28547081-C8A0EA67-4C13-481B-9BA3-6CE6DC8CB80FQ28554466-4EAB5864-B2E2-4DB0-BA4E-1C1EDDF1E3EBQ29306432-02EC60ED-D9F5-4175-89D9-5FC0A631271CQ29619167-AC86D9F4-21EE-4EE4-AEB3-4994C1DC20AFQ30249044-0CDD2D82-DD33-41B7-B0FF-4CD52352BA91Q30395320-53EB266D-9922-42D4-8F15-832F515D13CDQ30980068-9B91244B-584B-43F5-A581-58489F9BC0AEQ33276757-C6E04526-4AD5-4CD0-86F2-B0A8C7F7650DQ33279066-39844079-C32A-42DA-B884-093DBDC4FA6FQ33298467-8D2F410C-7F51-4102-A0C5-32B6CFC06DCEQ33304430-D7D0B2A4-12AB-4AD7-8C54-16F22852CFCCQ33313565-E1F7D2A3-974A-4A0A-8AC9-360B4724EB74Q33328938-F3E71A42-F8E5-4E70-833D-4E2A708ABF3CQ33344900-4A68F934-9AD4-42F2-B36C-7221ECD881FFQ33357073-70D6DA22-237B-44A6-8F7C-CD3CBBAA681DQ33371043-1B93F06C-E767-407E-AFCF-9326FDDB7597Q33384482-433AAF68-0121-43A3-907B-1D338BE720ACQ33395221-087ADA81-E62D-441D-8531-2F0A5FB1D9B8Q33434467-535BEB41-B4A5-4274-957B-979ED2D6AC90Q33481576-B1AAA7C7-C4EB-4D96-A2FE-0A843266003DQ33508667-865DF5C0-1694-4544-92DA-5CAB508773A2Q33530920-8941E27E-2C23-443A-9A5E-EBC0D197C3F9Q33565412-F8B02A57-9C6F-46C8-A8B7-CE56620ECE79Q33586454-8D84DFE8-0F95-4A7F-9DCF-59C2483A45B4Q33674933-69132FE1-B159-4C22-AFE3-95223E18FED8Q33704762-BFC8F7A5-EBB0-4954-803A-FCC211E40427Q33715256-E2F29DC5-5A7C-4F25-AE9F-25DFAB2B9F90Q33761137-980B4248-0D5E-42AE-BFC2-9113A24A4BFEQ33764147-21394A54-4C8B-4096-BB6D-BB642EFCCC89Q33828657-4BF6148F-FA05-400D-9E84-40E0F93998C5
P2860
Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Therapeutic response of multid ...... in southern Papua, Indonesia.
@ast
Therapeutic response of multid ...... in southern Papua, Indonesia.
@en
type
label
Therapeutic response of multid ...... in southern Papua, Indonesia.
@ast
Therapeutic response of multid ...... in southern Papua, Indonesia.
@en
prefLabel
Therapeutic response of multid ...... in southern Papua, Indonesia.
@ast
Therapeutic response of multid ...... in southern Papua, Indonesia.
@en
P2093
P2860
P921
P1476
Therapeutic response of multid ...... in southern Papua, Indonesia.
@en
P2093
A Brockman
A Ratcliff
E Kenangalem
E P Ebsworth
H Siswantoro
M D Edstein
P2860
P304
P356
10.1016/J.TRSTMH.2006.06.008
P577
2006-10-09T00:00:00Z